S&P 500   4,467.71
DOW   35,123.36
QQQ   367.91
2 Tech Stocks to Buy and One to Avoid in August
The “Wealth Pulse” That Sweeps Wall Street at 9:30AM (Ad)
3 Stocks to Buy No Matter Which Way Inflation Moves
3 Stocks to Buy After Heavy Insider Buying
66,000% upside on tiny biotech? (Ad)
2 Alternatives To Tesla (1 Safe, 1 More Risky)
The Rivian Market Is About To Shift Into A Higher Gear 
Fox Couldn't Air my #1 A.I. Pick - Get it Here. (Ad)
7 Best Fintech ETFs to Buy Now
How major US stock indexes fared Wednesday, 8/9/2023
S&P 500   4,467.71
DOW   35,123.36
QQQ   367.91
2 Tech Stocks to Buy and One to Avoid in August
The “Wealth Pulse” That Sweeps Wall Street at 9:30AM (Ad)
3 Stocks to Buy No Matter Which Way Inflation Moves
3 Stocks to Buy After Heavy Insider Buying
66,000% upside on tiny biotech? (Ad)
2 Alternatives To Tesla (1 Safe, 1 More Risky)
The Rivian Market Is About To Shift Into A Higher Gear 
Fox Couldn't Air my #1 A.I. Pick - Get it Here. (Ad)
7 Best Fintech ETFs to Buy Now
How major US stock indexes fared Wednesday, 8/9/2023
S&P 500   4,467.71
DOW   35,123.36
QQQ   367.91
2 Tech Stocks to Buy and One to Avoid in August
The “Wealth Pulse” That Sweeps Wall Street at 9:30AM (Ad)
3 Stocks to Buy No Matter Which Way Inflation Moves
3 Stocks to Buy After Heavy Insider Buying
66,000% upside on tiny biotech? (Ad)
2 Alternatives To Tesla (1 Safe, 1 More Risky)
The Rivian Market Is About To Shift Into A Higher Gear 
Fox Couldn't Air my #1 A.I. Pick - Get it Here. (Ad)
7 Best Fintech ETFs to Buy Now
How major US stock indexes fared Wednesday, 8/9/2023
S&P 500   4,467.71
DOW   35,123.36
QQQ   367.91
2 Tech Stocks to Buy and One to Avoid in August
The “Wealth Pulse” That Sweeps Wall Street at 9:30AM (Ad)
3 Stocks to Buy No Matter Which Way Inflation Moves
3 Stocks to Buy After Heavy Insider Buying
66,000% upside on tiny biotech? (Ad)
2 Alternatives To Tesla (1 Safe, 1 More Risky)
The Rivian Market Is About To Shift Into A Higher Gear 
Fox Couldn't Air my #1 A.I. Pick - Get it Here. (Ad)
7 Best Fintech ETFs to Buy Now
How major US stock indexes fared Wednesday, 8/9/2023
NASDAQ:SYRS

Syros Pharmaceuticals (SYRS) Price Target & Analyst Ratings

$3.73
+0.07 (+1.91%)
(As of 08/9/2023 ET)
Compare
Today's Range
$3.60
$3.80
50-Day Range
$2.83
$3.98
52-Week Range
$2.42
$10.29
Volume
56,522 shs
Average Volume
100,033 shs
Market Capitalization
$76.84 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$13.50

Syros Pharmaceuticals Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Buy
Based on 4 Analyst Ratings

Consensus Analyst Price Target

$13.50
261.93% Upside
High Prediction$15.00
Average Prediction$13.50
Low Prediction$11.00
TypeCurrent
8/10/22 to 8/10/23
1 Month Ago
7/11/22 to 7/11/23
3 Months Ago
5/12/22 to 5/12/23
1 Year Ago
8/10/21 to 8/10/22
Consensus Rating
Buy
Buy
Buy
Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
4 Buy rating(s)
4 Buy rating(s)
5 Buy rating(s)
5 Buy rating(s)
Hold
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$13.50$15.75$32.60$120.00
Predicted Upside261.93% Upside334.18% Upside634.04% Upside381.66% Upside
Get Syros Pharmaceuticals Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for SYRS and its competitors with MarketBeat's FREE daily newsletter.


SYRS Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

SYRS Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Syros Pharmaceuticals Stock vs. The Competition

TypeSyros PharmaceuticalsMedical CompaniesS&P 500
Consensus Rating Score
3.00
2.65
2.48
Consensus RatingBuyModerate BuyHold
Predicted Upside261.93% Upside5,107.94% Upside636.81% Upside
News Sentiment RatingNeutral News
Neutral News
Positive News

Historical Target Prices and Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
8/9/2023Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$16.00 ➝ $11.00+205.55%
5/11/2023JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Jason Butler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Target$16.00 ➝ $15.00+337.32%
3/3/2023HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy$15.00+298.94%
3/2/2023Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform$15.00 ➝ $13.00+245.74%
(Data available from 8/10/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)












SYRS Price Target - Frequently Asked Questions

What is Syros Pharmaceuticals's consensus rating and price target?

According to the issued ratings of 4 analysts in the last year, the consensus rating for Syros Pharmaceuticals stock is Buy based on the current 4 buy ratings for SYRS. The average twelve-month price prediction for Syros Pharmaceuticals is $13.50 with a high price target of $15.00 and a low price target of $11.00. Learn more on SYRS's analyst rating history.

Do Wall Street analysts like Syros Pharmaceuticals more than its competitors?

Analysts like Syros Pharmaceuticals more than other Medical companies. The consensus rating for Syros Pharmaceuticals is Buy while the average consensus rating for medical companies is Moderate Buy. Learn more on how SYRS compares to other companies.

Does Syros Pharmaceuticals's stock price have much upside?

According to analysts, Syros Pharmaceuticals's stock has a predicted upside of 270.75% based on their 12-month price targets.

What analysts cover Syros Pharmaceuticals?

Syros Pharmaceuticals has been rated by Piper Sandler in the past 90 days.


Stock Ratings Reports and Tools

This page (NASDAQ:SYRS) was last updated on 8/10/2023 by MarketBeat.com Staff

My Account -